Verano Holdings (VRNO) Other Operating Expenses (2021 - 2026)
Verano Holdings (VRNO) reported Other Operating Expenses of -$27000.0 for Q1 2026, up 67.86% year-over-year from -$16085.1 in Q1 2025, and up 97.39% quarter-over-quarter from -$1.0 million in Q4 2025.
Verano Holdings (VRNO) Other Operating Expenses (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Other Operating Expenses data on file, last reported at -$27000.0 in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at -$27000.0, up 67.86% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 82.72% YoY), and the FY2025 annual result was -$2.0 million, down 78.08% from the prior year.
- Other Operating Expenses climbed to -$27000.0 in Q1 2026 per VRNO's latest filing, from -$1.0 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $1.4 million in Q3 2022 and troughed at -$1.0 million in Q4 2025.
- A 5-year average of -$272062.5 and a median of -$291000.0 in 2023 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2022 and 2024: Other Operating Expenses jumped 16133.33% in 2022, then slumped 313.43% in 2024.
- A 5-year view of Other Operating Expenses shows it stood at -$408000.0 in 2022, then plunged by 39.22% to -$568000.0 in 2023, then soared by 38.73% to -$348000.0 in 2024, then sank by 197.13% to -$1.0 million in 2025, then surged by 97.39% to -$27000.0 in 2026.
- Business Quant data shows VRNO's Other Operating Expenses at -$27000.0 in Q1 2026, -$1.0 million in Q4 2025, and -$620000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27,000.00 |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | -620,000.00 |
| Jun 30, 2025 | -212,000.00 |
| Mar 31, 2025 | -84,000.00 |
| Dec 31, 2024 | -348,000.00 |
| Sep 30, 2024 | -604,000.00 |
| Mar 31, 2024 | -143,000.00 |
| Dec 31, 2023 | -568,000.00 |
| Sep 30, 2023 | -234,000.00 |
| Jun 30, 2023 | -388,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | -408,000.00 |
| Sep 30, 2022 | 1.44 Mn |
| Jun 30, 2022 | -203,000.00 |
| Mar 31, 2022 | -990,000.00 |
| Dec 31, 2021 | -647,000.00 |
| Sep 30, 2021 | -9,000.00 |
| Jun 30, 2021 | -429,000.00 |